Surgeons at Massachusetts General Hospital successfully completed a second genetically edited pig kidney transplant, advancing the hospital’s pioneering xenotransplantation program. The procedure represents a major step toward addressing organ shortages.
Medical ethicists and researchers worldwide are watching the outcomes closely. If successful long-term, the approach could eventually help thousands of patients waiting for kidney transplants.